Richard Look

Title: Richard Look: Innovator in Pharmaceutical Chemistry

Introduction

Richard Look is a notable inventor based in Trenton, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target vasopressin receptors. With a total of 2 patents to his name, his work has the potential to impact the treatment of various cardiovascular and renal conditions.

Latest Patents

Richard Look's latest patents focus on nonpeptide substituted spiroheterobenzazepines, which are useful as vasopressin receptor antagonists. These compounds are designed to treat conditions associated with vasopressin receptor activity, such as increased vascular resistance and cardiac insufficiency. His inventions aim to address serious health issues, including congestive heart failure, hyponatremia, and hypertension. The patents also disclose pharmaceutical compositions that comprise these compounds and methods for treating conditions like coronary vasospasm, cardiac ischemia, liver cirrhosis, renal insufficiency, and more.

Career Highlights

Richard Look is currently employed at Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex medical conditions.

Collaborations

Some of Richard's coworkers include Min Amy Xiang and Mona Patel, who contribute to the collaborative environment at Janssen Pharmaceutica NV.

Conclusion

Richard Look's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patents not only advance scientific knowledge but also hold promise for improving patient outcomes in various medical conditions.